Kristin Brogaard received her PhD in Molecular Biology from Northwestern University developing a novel epigenetic technology that allowed for single-base pair resolution mapping of DNA binding proteins genome-wide. To continue her training in technology development, Dr. Brogaard worked as a postdoc with Dr. Leroy Hood, a pioneer in personalized medicine technologies, developing new methods for low-level antibody capture and quantification in blood for early detection of autoimmune diseases. After her postdoc, she continued to work with Dr. Hood as the director of a human-subjects clinical trial based on Dr. Hood’s vision of the intersection of systems biology and personalized medicine. From the results of the clinical trial, the team launched a scientific wellness start-up, Arivale, where Kristin was the Director of Program Management and responsible for directing the formation, communication, resourcing and tracking of Arivale’s quarterly strategic objectives and their associated key performance indicators. 

Kristin co-founded Inherent Biosciences Inc. and acts as Chief Scientific Officer to combine her passion for epigenetics and personalized medicine. At Inherent, she uses epigenetic discoveries to answer unexplained medical conditions, providing better diagnostics and treatment plans. Outside of work Kristin loves to hike, cook, and spend time with her husband, two kids, and crazy dog.